NASDAQ:BIOT Biotech Acquisition (BIOT) Stock Price, News & Analysis → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free BIOT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.14▼$10.1950-Day Range$10.08▼$10.3252-Week Range$8.30▼$10.41Volume44,400 shsAverage Volume244,605 shsMarket Capitalization$291.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Biotech Acquisition alerts: Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. About Biotech Acquisition Stock (NASDAQ:BIOT)Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Read More Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. BIOT Stock News HeadlinesMay 29, 2024 | finance.yahoo.comJeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billionMay 29, 2024 | msn.comMerck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market PresenceMay 28, 2024 | bizjournals.comD.C.’s Vanda Pharmaceuticals rejects acquisition offer — againMay 23, 2024 | finance.yahoo.comResource Label Group expands RLG Healthcare business with acquisition of Beyer GraphicsMay 22, 2024 | finance.yahoo.comSixPeaks, a new obesity biotech, starts up with an option to sell to AstraZenecaMay 22, 2024 | markets.businessinsider.comHBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin AmericaMay 22, 2024 | finance.yahoo.comGenmab acquires biotechnology company ProfoundBio in $1.8bn dealMay 22, 2024 | msn.comKKR, Blackstone, Carlyle, Mankind Pharma eye acquisition of Advent-owned Bharat Serums & VaccinesMay 20, 2024 | msn.comAjooni Biotech Ltd's Rs 43.81 crores Rights opens on May 21, 2024May 17, 2024 | markets.businessinsider.comBuy Rating Affirmed for Ultragenyx Pharmaceutical Based on Clinical Updates and Market Valuation DisconnectMay 16, 2024 | msn.comJohnson & Johnson to buy dermatology-focused biotech ProteologixMay 16, 2024 | msn.comMankind Pharma: Strong Q4, Acquisition Reports Not Enough To Power StockMay 15, 2024 | bizjournals.comRaleigh clinical research firm expands in four states with acquisitionMay 15, 2024 | msn.comPharmaceutical giant Bayer AG trims workforce by 1500 amid slight sales declineMay 15, 2024 | msn.comBiopharmaceutical mergers and acquisitions surge to new highsMay 10, 2024 | bizjournals.comA second co-founder has left Forge Biologics following its more than $600M acquisitionMay 8, 2024 | bizjournals.comD.C. biotech mulling sweetened acquisition offerMay 8, 2024 | msn.comMyonex Expands Pharmaceutical Services with Acquisition of CreapharmMay 8, 2024 | finance.yahoo.comArbor Biotechnologies Announces Acquisition of SerendipityMay 3, 2024 | finance.yahoo.comEphicacy Consulting Group Completes Acquisition of Advance Research AssociatesMay 2, 2024 | bizjournals.comHow Moderna's cost-cutting moves hit a Bay Area biotechMay 1, 2024 | bizjournals.comAccounting giant wants to grow Albany footprint after Nuvalence acquisitionApril 29, 2024 | msn.comDeciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO PharmaceuticalApril 29, 2024 | markets.businessinsider.comDeciphera Up In Pre-market On News Of Acquisition By ONO Pharmaceutical For About $2.4 BlnApril 26, 2024 | msn.comEli Lilly’s acquisition of Nexus facility marks a new era for Pleasant Prairie’s pharmaceutical landscapeSee More Headlines Receive BIOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:BIOT CUSIPN/A CIK1825413 Webbioacq.com Phone212-227-1905FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,860,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-42.22% Return on Assets3.48% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.95) per share Price / Book-10.68Miscellaneous Outstanding Shares28,750,000Free Float23,288,000Market Cap$291.81 million OptionableNot Optionable Beta-0.12 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Michael Shleifer Ph.D. (Age 48)Chairman & CEO Mr. Thomas Fratacci (Age 44)CFO & Treasurer Mr. Ivan Jarry (Age 44)Chief Operating Officer Mr. Albert F. Hummel M.B.A. (Age 76)Chief Investment Officer & Director Key CompetitorsMirum PharmaceuticalsNASDAQ:MIRMCalliditas Therapeutics AB (publ)NASDAQ:CALTEnliven TherapeuticsNASDAQ:ELVNCollegium PharmaceuticalNASDAQ:COLLProthenaNASDAQ:PRTAView All Competitors This page (NASDAQ:BIOT) was last updated on 6/4/2024 by MarketBeat.com Staff From Our PartnersNvidia’s Quiet $1 Trillion PivotWeiss RatingsThe Only Energy Play You Should Be Looking AtWealthpin ProClaim Your Complimentary Bitcoin RewardCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaElon Musk’s Final Masterpiece: “X-9840”Paradigm PressPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchCollapse of the Petrodollar Colonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotech Acquisition Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.